Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study

J Mark FitzGerlad; Malcolm R Sears; Louis-Philippe Boulet; Allan B Becker; Andrew R McIvor; Pierre Ernst; Natasha M Smiljanic-Georgijev; Joanna SM Lee

doi:10.1155/2003/298039

Canadian Respiratory Journal (Jan 2003)

Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study

J Mark FitzGerlad,
Malcolm R Sears,
Louis-Philippe Boulet,
Allan B Becker,
Andrew R McIvor,
Pierre Ernst,
Natasha M Smiljanic-Georgijev,
Joanna SM Lee

Affiliations

J Mark FitzGerlad: University of British Columbia, Vancouver, British Columbia, Canada
Malcolm R Sears: McMaster University, Hamilton, Ontario, Canada
Louis-Philippe Boulet: Laval University, Quebec City, Quebec, Canada
Allan B Becker: University of Manitoba, Winnipeg, Manitoba, Canada
Andrew R McIvor: Dalhousie University, Halifax, Nova Scotia, Canada
Pierre Ernst: McGill University, Montreal, Quebec, Canada
Natasha M Smiljanic-Georgijev: AstraZeneca Canada, Mississauga, Ontario, Canada
Joanna SM Lee: AstraZeneca Canada, Mississauga, Ontario, Canada

DOI: https://doi.org/10.1155/2003/298039
Journal volume & issue: Vol. 10, no. 8
pp. 427 – 434

Abstract

Read online

BACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal